| Jul 31 |
Regeneron Pharmaceuticals Q2 2024 Earnings Preview
|
| Jul 31 |
Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation
|
| Jul 30 |
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
|
| Jul 30 |
Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth
|
| Jul 30 |
Roche’s Vabysmo challenges Eylea dominance with third European indication
|
| Jul 30 |
BioNTech posts mid-stage win for mRNA cancer drug with Regeneron’s Libtayo
|
| Jul 30 |
The Zacks Analyst Blog Highlights Goldman Sachs, RTX, Regeneron and Optex Systems
|
| Jul 29 |
Top Analyst Reports for Goldman Sachs, RTX & Regeneron
|
| Jul 29 |
Countdown to Regeneron (REGN) Q2 Earnings: Wall Street Forecasts for Key Metrics
|
| Jul 29 |
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
|
